The Saudi Arabia / Riyadh Market
Riyadh is the center of Saudi Arabia's Vision 2030 technology transformation — the most consequential government-led digitization program in the Gulf, with mandated technology localization, data residency requirements under the Saudi Personal Data Protection Law (PDPL), and NCA cybersecurity framework obligations that apply to every system touching Saudi data. The scale of procurement is substantial; the compliance requirements are exacting.
Pharmaceuticals & Life Sciences organizations operating in Saudi Arabia need Saudi PDPL compliance architecture, NCA Essential Cybersecurity Controls (ECC) mapped to their infrastructure, and CITC licensing requirements where applicable. Engineering teams that deploy into Saudi Arabia with generic GDPR-adjacent compliance documentation are rejected at the regulatory review stage. We deploy with Saudi-specific frameworks built in from the first architectural decision.
Compliance Coverage
Every system we deploy for Pharmaceuticals & Life Sciences in Saudi Arabia / Riyadh is FDA 21 CFR Part 11-compliant from architecture through deployment. FDA 21 CFR Part 11 and HIPAA compliance is enforced automatically at every commit — not assessed after the fact.
Engagement Scope
Duration: 8–16 weeks
A focused team deployed against a single Pharmaceuticals & Life Sciences platform in Saudi Arabia / Riyadh. FDA 21 CFR Part 11 and HIPAA-compliant architecture from day one. Fixed price, fixed output, no discovery phase.
Duration: 3–9 months
40–100 engineers running parallel workstreams across a Pharmaceuticals & Life Sciences transformation in Saudi Arabia / Riyadh. Multi-system compliance governance and FDA 21 CFR Part 11 and HIPAA certification maintained across the full program.
Duration: 6–18 months
100–250+ engineers owning the complete technology infrastructure for a Pharmaceuticals & Life Sciences organization in Saudi Arabia / Riyadh. Full FDA 21 CFR Part 11 and HIPAA compliance across every system, every integration, every deployment.